Ligand validation:3OMI

DMU: DECYL-BETA-D-MALTOPYRANOSIDE

DMU is a Ligand Of Interest in 3OMI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OMI_DMU_B_301	85%	65%	0.096	0.96	0.44	0.9	-	2	0	0	100%	1
3OMI_DMU_B_303	42%	72%	0.176	0.897	0.48	0.61	-	-	0	0	100%	0.75
3OMI_DMU_B_302	33%	65%	0.186	0.863	0.52	0.82	-	2	0	0	100%	0.75
3OMI_DMU_A_603	16%	63%	0.173	0.804	0.55	0.84	-	1	1	0	67%	0.5
3OMI_DMU_D_301	15%	70%	0.19	0.806	0.54	0.61	-	-	1	0	70%	0.3485
3OMI_DMU_B_304	13%	68%	0.207	0.805	0.55	0.68	-	-	0	0	70%	0.5227
3OMI_DMU_C_603	12%	67%	0.28	0.864	0.54	0.74	-	-	0	0	70%	0.5227
3OMI_DMU_D_302	10%	70%	0.267	0.826	0.56	0.6	-	-	0	0	70%	0.5227
3OMI_DMU_C_602	9%	64%	0.362	0.85	0.57	0.8	-	-	2	0	100%	1
3OMI_DMU_A_602	5%	65%	0.229	0.705	0.51	0.83	-	1	0	0	67%	0.6667
3OMI_DMU_C_604	0%	62%	0.566	0.141	0.63	0.81	-	1	1	0	70%	0.5227
6PW0_DMU_A_608	86%	24%	0.098	0.967	1.89	1.24	9	4	1	0	100%	1
2GSM_DMU_A_5001	83%	60%	0.085	0.942	0.5	1.02	-	1	0	0	100%	1
6CI0_DMU_A_602	82%	27%	0.092	0.947	1.91	1.06	10	3	0	0	100%	1
3OM3_DMU_B_1	82%	56%	0.096	0.951	0.59	1.1	1	3	0	0	100%	1
3FYI_DMU_A_573	82%	62%	0.088	0.942	0.5	0.96	-	3	0	0	100%	1
7VU0_DMU_A_501	85%	33%	0.079	0.964	1.62	1.06	8	2	0	0	88%	0.8788
7COH_DMU_A_526	82%	44%	0.09	0.946	1.05	1.12	2	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.